News Roundup: XpresSpa Group, Inc. (NASDAQ:XSPA) & NantKwest, Inc. (NASDAQ:NK)

7

XpresSpa Group, Inc. (NASDAQ:XSPA)

XpresSpa Group, Inc. operates as a health and wellness company. It provides airport spa, cryotherapy, compression therapy and salt chambers solutions. The company also offers travel products and accessories. It operates primarily in the United States, Holland and the United Arab Emirates. XpresSpa Group Inc., formerly known as FORM Holdings Corp., is based in New York, United States.

XpresSpa Group, Inc. (NASDAQ:XSPA)’s Financial Overview

XpresSpa Group, Inc. (NASDAQ) surged 1.05% yesterday to close its trading session at $0.19. The company has 1 year Price Target of $0.9. XpresSpa Group, Inc. has 52-Week high of $1.29 and 52-Week Low of $0.11. The stock touched its 52-Week High on 1.44 and 52-Week Low on 0.11. The stock traded with the volume of 1.19 Million shares yesterday. The firm shows the market capitalization of $6.6 Million.

XpresSpa Group, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.11/share against the analyst consensus estimate of $-0.12/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 8.3%.

The firm is trading with SMA20 of 9.99 Percent, SMA50 of 7.23 Percent and SMA200 of -38.94 percent. XpresSpa Group, Inc. has P/S value of 0.17 while its P/B value stands at 0.47. Similarly, the company has Return on Assets of -96.3 percent, Return on Equity of -197.8 percent and Return on Investment of 19.6 Percent. The company shows Gross Margin and Operating Margin of 22.4 percent and -76.4 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 1 analysts offering 12-month price forecasts for XpresSpa Group Inc have a median target of 0.90, with a high estimate of 0.90 and a low estimate of 0.90. The median estimate represents a +368.51% increase from the last price of 0.19.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

NantKwest, Inc. (NASDAQ:NK)

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company’s product candidates include aNK, haNK and taNK for the treatment of cancers, infectious and inflammatory diseases. It is focused on harnessing the power of the innate immune system by using the natural killer cell. NantKwest, Inc. is headquartered in Cardiff-by-the-Sea, California.

NantKwest, Inc. (NASDAQ:NK)’s Financial Outlook

The 2 analysts offering 12-month price forecasts for NantKwest Inc have a median target of 2.75, with a high estimate of 3.50 and a low estimate of 2.00. The median estimate represents a +96.43% increase from the last price of 1.40.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, NantKwest, Inc. has a Consensus Recommendation of 3. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged 0.72% and closed its last trading session at $1.4. The company has the market capitalization of $110.1 Million. The stock has 52-week high of $5.47 and 52-Week low of $0.93. The firm touched its 52-Week high on 5.47 and 52-Week low on 0.93. The company has volume of 124216 shares. The company has a total of 78.64 Million shares outstanding.

NantKwest, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.3/share where the analyst estimated EPS was $-0.37/share. The difference between the actual and Estimated EPS is $0.07. This shows a surprise factor of 18.9 percent.

The company has YTD performance of 20.69 percent. Beta for NantKwest, Inc. stands at 3.13 while its ATR (average true range) is 0.15. The company has Weekly Volatility of 10.87%% and Monthly Volatility of 12.37%%.

NantKwest, Inc. has distance from 20-day Simple Moving Average (SMA20) of 13.41%, Distance from 50-Day Simple Moving Average of -20.95 percent and Distance from 200-Day Simple Moving Average of -53.42%.

The Company currently has ROA (Return on Assets) of -46.3 percent, Return on Equity (ROE) of -54.2 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.

SHARE